We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+4.88%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
-$2.57B
(-4.7%)
Cap. Flow
-$5.24B
Cap. Flow
% of AUM
-10.02%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
808
New
29
Increased
364
Reduced
339
Closed
21
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$401M |
| 2 |
Mohawk Industries
MHK
|
+$236M |
| 3 |
Knight Transportation
KNX
|
+$212M |
| 4 |
Adobe
ADBE
|
+$179M |
| 5 |
Yum China
YUMC
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$557M |
| 2 |
Wells Fargo
WFC
|
+$553M |
| 3 |
JPMorgan Chase
JPM
|
+$394M |
| 4 |
Tenaris
TS
|
+$344M |
| 5 |
PNC Financial Services
PNC
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.02% |
| 2 | Technology | 13.85% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Healthcare | 10.88% |
| 5 | Consumer Staples | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
Ralph Lauren
RL
$23.3B
| $5.97M | 0.01% |
57,625
+20,263
| +54% | +$1.87M |
2017 Q3
1 quarter
|
|
|
LAQ
527
DELISTED
Aberdeen Latin America Equity Fund
LAQ
| $5.94M | 0.01% |
222,202
| – | – |
2017 Q3
1 quarter
|
|
528
Eversource Energy
ES
$25B
| $5.92M | 0.01% |
93,765
-5,199
| -5% | -$329K |
2017 Q3
1 quarter
|
|
529
Ituran Location and Control
ITRN
$987M
| $5.91M | 0.01% |
172,746
-11,200
| -6% | -$401K |
2017 Q3
1 quarter
|
|
530
Illumina
ILMN
$40.6B
| $5.91M | 0.01% |
27,789
+644
| +2% | +$133K |
2017 Q3
1 quarter
|
|
|
ALXN
531
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.87M | 0.01% |
49,041
+526
| +1% | +$64.1K |
2017 Q3
1 quarter
|
|
532
Hormel Foods
HRL
$11.2B
| $5.85M | 0.01% |
160,792
-1,839
| -1% | -$61.8K |
2017 Q3
1 quarter
|
|
533
DELISTED
Kellanova
K
| $5.76M | 0.01% |
90,157
+2,137
| +2% | +$129K |
2017 Q3
1 quarter
|
|
|
ETFC
534
DELISTED
E*Trade Financial Corporation
ETFC
| $5.71M | 0.01% |
115,248
-158,126
| -58% | -$7.26M |
2017 Q3
1 quarter
|
|
535
Harley-Davidson
HOG
$2.87B
| $5.7M | 0.01% |
112,053
+649
| +0.6% | +$31.6K |
2017 Q3
1 quarter
|
|
536
AXIS Capital
AXS
$7.22B
| $5.67M | 0.01% |
112,706
-16,912
| -13% | -$901K |
2017 Q3
1 quarter
|
|
537
Entergy
ETR
$50B
| $5.66M | 0.01% |
138,960
-118,764
| -46% | -$4.97M |
2017 Q3
1 quarter
|
|
538
Northern Trust
NTRS
$30.8B
| $5.65M | 0.01% |
56,584
+515
| +0.9% | +$49.1K |
2017 Q3
1 quarter
|
|
539
Fortive
FTV
$17.6B
| $5.58M | 0.01% |
122,312
+7,393
| +6% | +$339K |
2017 Q3
1 quarter
|
|
540
Republic Services
RSG
$70.6B
| $5.5M | 0.01% |
81,341
+22
| +0% | +$1.42K |
2017 Q3
1 quarter
|
|
541
Quest Diagnostics
DGX
$26.5B
| $5.49M | 0.01% |
55,776
-86,449
| -61% | -$8.2M |
2017 Q3
1 quarter
|
|
542
Pricesmart
PSMT
$5.23B
| $5.49M | 0.01% |
63,800
-19,000
| -23% | -$1.62M |
2017 Q3
1 quarter
|
|
543
Clorox
CLX
$10.5B
| $5.49M | 0.01% |
36,918
+675
| +2% | +$91.8K |
2017 Q3
1 quarter
|
|
544
Embotelladora Andina Series A
AKO.A
$3.83B
| $5.46M | 0.01% |
+206,000
| New | +$5.26M |
2017 Q4
0 quarters
|
|
545
Nebius Group N.V.
NBIS
$48.5B
| $5.41M | 0.01% |
165,150
+21,368
| +15% | +$697K |
2017 Q3
1 quarter
|
|
546
DaVita
DVA
$12.1B
| $5.41M | 0.01% |
74,835
+2,429
| +3% | +$149K |
2017 Q3
1 quarter
|
|
547
Labcorp
LH
$26.4B
| $5.4M | 0.01% |
39,418
+764
| +2% | +$101K |
2017 Q3
1 quarter
|
|
|
SINA
548
DELISTED
Sina Corp
SINA
| $5.38M | 0.01% |
53,686
+5,703
| +12% | +$609K |
2017 Q3
1 quarter
|
|
549
Regeneron Pharmaceuticals
REGN
$82.6B
| $5.37M | 0.01% |
14,274
+522
| +4% | +$211K |
2017 Q3
1 quarter
|
|
550
American Water Works
AWK
$26.7B
| $5.35M | 0.01% |
58,526
+799
| +1% | +$70.6K |
2017 Q3
1 quarter
|
|
Similar funds
Aberdeen Group's Q4 2017 Portfolio in Review
As of Q4 2017, Aberdeen Group held 808 positions worth $52.3B, down 4.7% from $54.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $5.24B in Q4 2017, closing 21 positions and reducing 339 holdings. Its most notable exit was CR Bard Inc., an estimated $76.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Knight Transportation worth $225M.
- Aberdeen Group's largest Q4 2017 buy was Knight Transportation: 5,155,363 shares worth $225M.
- Aberdeen Group added most to DuPont de Nemours in Q4 2017, an estimated $401M increase.
- Aberdeen Group's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $557M.
- Aberdeen Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $76.5M.
- Aberdeen Group's ten largest holdings make up 20% of its $52.3B portfolio in Q4 2017.
- Aberdeen Group opened 29 new positions and closed 21 in Q4 2017.
- Aberdeen Group's portfolio value fell 4.7% quarter-over-quarter to $52.3B.
Based on Aberdeen Group's 13F filing for Q4 2017, filed 12 Feb 2018.